News

Tolebrutinib did not show superiority over Aubagio (teriflunomide) in reducing relapse rates or MRI-detected inflammatory ...
Assessing multiple sclerosis disease activity using the MSDA blood biomarker test can help guide decisions about care, per a study.
An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...
Columnist Desiree Lama shares what she wishes she'd been told after her diagnosis of multiple sclerosis at age 17.
Christina Applegate got emotional opening up about her struggle with multiple sclerosis, nearly four years after she was ...
Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...
Pree, 27, adult diaper influencer, talks with PEOPLE about her multiple sclerosis journey and what inspired her to share her story on social media Pree/BumblePree At 19, Pree was diagnosed with ...
The National Multiple Sclerosis Society (NMSS) has signed a Memorandum of Understanding (MoU) with six leading universities ...
Depression and anxiety have been well documented in people with multiple sclerosis (MS), but often are undiagnosed or ...
Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral ...
By studying the effects of the nasal anti-CD3 in a ... Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped ...